PPARγ-independent increase in glucose uptake and adiponectin abundance in fat cells

Endocrinology

Volumn 152, Issue 10, 2011, Pages 3648-3660

  Dubuisson, Olga ^a   Dhurandhar, Emily J ^a   Krishnapuram, Rashmi ^a   Kirk Ballard, Heather ^a   Gupta, Alok K ^a   Hegde, Vijay ^a   Floyd, Elizabeth ^a   Gimble, Jeffrey M ^a   Dhurandhar, Nikhil V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; 2 CHLORO 5 NITROBENZANILIDE; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; GLUCOSE;

ADENOVIRUS; ADENOVIRUS 2; ADENOVIRUS 36; ADENOVIRUS INFECTION; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DOWN REGULATION; FIBROBLAST; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; UPREGULATION; AGED; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; DRUG ANTAGONISM; FEMALE; MALE; METABOLISM; MIDDLE AGED; MOUSE; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; AGED; ANILIDES; ANIMALS; CELLS, CULTURED; FEMALE; GLUCOSE; HUMANS; MALE; MICE; MIDDLE AGED; NIH 3T3 CELLS; PPAR GAMMA;

EID: 80053137538     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0225     Document Type: Article

References (53)

1. Nawrocki AR, Scherer PE 2005 Keynote review: the adipocyte as a drug discovery target. Drug Discov Today 10:1219-1230 (Pubitemid 41411432)
2. Hauner H, Röhrig K, Spelleken M, Liu LS, Eckel J 1998 Development of insulin-responsive glucose uptake and GLUT4 expression in differentiating human adipocyte precursor cells. Int J Obes Relat Metab Disord 22:448-453 (Pubitemid 28211973)
3. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, Cam MC, Cushman SW, Smith U 2004 Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 317:1045-1051 (Pubitemid 38496415)
4. Spiegelman BM 1998 PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514 (Pubitemid 28160438)
5. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK 1995 Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921-7925
6. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156
7. Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, Imamura T, Verma IM, Olefsky JM 2007 Suppression of PPAR-γ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 293:E219-E227 (Pubitemid 47105935)
8. Choi SS, Cha BY, Iida K, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT 2011 Artepillin C; as a PPARγ ligand; enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Biochem Pharmacol 81:925-933
9. Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT 2009 Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci 84:908-914
10. Staels B, Fruchart JC 2005 Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54:2460-2470 (Pubitemid 41134276)
11. Larsen TM, Toubro S, Astrup A 2003 PPARγ agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27:147-161 (Pubitemid 36255796)
12. Semenkovich CF 2005 TZDs and diabetes: testing the waters. Nat Med 11:822-824 (Pubitemid 41161107)
13. Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA 2007 Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 298:2634-2643 (Pubitemid 350254955)
14. Knouff C, Auwerx J 2004 Peroxisome proliferator-activated receptor-γ calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev 25:899-918 (Pubitemid 39657772)
15. Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti Jr JR 2000 Aselective peroxisome proliferator-activated receptor-γ (PPARγ) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 14:1425-1433
16. Wigand R, Gelderblom H, Wadell G 1980 New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol 64:225-233 (Pubitemid 10050509)
17. Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, Permana P, De Courten B, Yu M, Ravussin E, Gimble JM, Dhurandhar NV 2008 Adipogenic human adenovirus Ad-36 induces commitment, differentiation and lipid accumulation in human adipose-derived stem cells. Stem Cells 26:969-978
18. Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV 2009 Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity 17:657-664
19. Rogers PM, Fusinski K, Rathod MA, Loiler S, Pasarica M, Shaw M, Kilroy G, Sutton G, McAllister E, Mashtalir N, Gimble J, Holland T, NV D 2007 Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obesity 32 397-406 (Pubitemid 351414816)
20. Wang ZQ, Cefalu WT, Zhang XH, Yu Y, Qin J, Son L, Rogers PM, Mashtalir N, Bordelon JR, Ye J, Dhurandhar NV 2008 Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 57:1805-1813
21. Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang Z, Dasuri K, Babin S, Gupta A, Markward N, Cefalu WT, Dhurandhar NV 2008 Metabolically favorable remodeling of human adipose tissue by human adenovirus Ad-36. Diabetes 57:2321-2331
22. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL 2000 Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 24:989-996 (Pubitemid 30618118)
23. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL 2001 Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 25:990-996 (Pubitemid 32566053)
24. Pasarica M, Shin AC, Yu M, Ou Yang HM, Rathod M, Jen KL, MohanKumar S, MohanKumar PS, Markward N, Dhurandhar NV 2006 Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity 14:1905-1913 (Pubitemid 46121920)
25. Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N, Sothern MS, Larsen-Meyer E, Chalew S, Bennett B, Gupta AK, Greenway FL, Johnson W, Brashear M, Reinhart G, Rankinen T, Bouchard C, Cefalu WT, Ye J, Javier R, Zuberi A, Dhurandhar NV 2011 A template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 300:E779-E789
26. Kuda O, Stankova B, Tvrzicka E, Hensler M, Jelenik T, Rossmeisl M, Flachs P, Kopecky J 2009 Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet. J Physiol Pharmacol 60:135-140
27. Fernandes-Santos C, Evangelista Carneiro R, De Souza Mendonca L, Barbosa Aguila M, Mandarim-de-Lacerda CA 2009 Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 38:e80-e86
28. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG 2002 Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640-6650 (Pubitemid 34547354)
29. Gupta AK, Smith SR, Greenway FL, Bray GA 2009 Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome. Diabetes Obes Metab 11:330-337
30. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, Augustus AS 2005 Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes 29:281-286 (Pubitemid 40333226)
31. Dubois S, Halvorsen Y, Ravussin E, Gimble J 2005 Primary stromal cell culture from adipose tissue. From liposuction to needle biopsy. Adipocytes 1:139-144
32. Sen A, Lea-Currie YR, Sujkowska D, Franklin DM, Wilkison WO, Halvorsen YD, Gimble JM 2001 Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem 81:312-319 (Pubitemid 32298263)
33. Klip A 2009 The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab 34:481-487
34. Rathod MA, Rogers PM, Dhurandhar NV 2006 Human adenovirus Ad-36 infection induces differentiation and replication of preadipocytes. Obes Rev 7:138
35. Farmer SR 2005 Regulation of PPARγ activity during adipogenesis. Int J Obes 29 (Suppl 1):S13-S16
36. Fu Y, Luo N, Klein RL, Garvey WT 2005 Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46:1369-1379 (Pubitemid 43109800)
37. Tamori Y, Masugi J, Nishino N, Kasuga M 2002 Role of peroxisome proliferator-activated receptor-γ in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51:2045-2055 (Pubitemid 34729007)
38. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881 (Pubitemid 34015133)
39. Ravussin E 2002 Adiponectin enhances insulin action by decreasing ectopic fat deposition. Pharmacogenomics J 2:4-7 (Pubitemid 34982193)
40. You T, Yang R, Lyles MF, Gong D, Nicklas BJ 2005 Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 288:E741-E747 (Pubitemid 40397209)
41. Pajvani UB, Scherer PE 2003 Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 3:207-213 (Pubitemid 38906774)
42. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE 2006 Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J Biol Chem 281:2654-2660 (Pubitemid 43845727)
43. Shen Z, Liang X, Rogers CQ, Rideout D, You M 2010 Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 298:G364-G374
44. McLaughlin TM, Liu T, Yee G, Abbasi F, Lamendola C, Reaven GM, Tsao P, Cushman SW, Sherman A 2010 Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity 18:926-931
45. Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ, Heydari AR, Dhurandhar NV 2007 Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes 31:87-96 (Pubitemid 46006020)
46. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM 1999 PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617 (Pubitemid 29531140)
47. Nugent C, Prins JB, Whitehead JP, Savage D, Wentworth JM, Chatterjee VK, O'Rahilly S 2001 Potentiation of glucose uptake in 3T3-L1 adipocytes by PPARγ agonists is maintained in cells expressing a PPARγ dominant-negative mutant: evidence for selectivity in the downstream responses to PPARγ activation. Mol Endocrinol 15:1729-1738
48. Pereira RI, Leitner JW, Erickson C, Draznin B 2008 Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3′-kinase. Life Sci 83:638-643
49. Boden G, Cheung P, Mozzoli M, Fried SK 2003 Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 52:753-759 (Pubitemid 36896311)
50. Whigham LD, Israel BA, Atkinson RL 2006 Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 290:R190-R194
51. Hanlon GW 2007 Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 30:118-128 (Pubitemid 46977193)
52. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F 1996 An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376 (Pubitemid 26353341)
53. Crompton AM, Kirn DH 2007 From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr Cancer Drug Targets 7:133-139 (Pubitemid 46348627)